RxDoctor Payments Data

Tate Jechow, PA

Physician Assistant · Houston, TXNPI 1053928382

Payments from drug & device makers

$4,577in general payments, 2019–2025

Across 101 payments — averaging $45.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Baxter Healthcare$607
  • Getinge USA Sales, LLC$432
  • Atricure, Inc.$406
  • Abiomed$301
  • Medical Device Business Services, Inc.$231
  • plus $670 from 11 others

What the payments were for

  • Food & beverage$4,36595%
  • Education$2125%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,577 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$34,718
Medicare patients
155
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$6,360
Colchicine14$715
Amiodarone Hcl26$404
Atorvastatin Calcium32$336
Metoprolol Tartrate69$271
ClopidogrelClopidogrel Bisulfate32$229
Potassium Chloride41$202
Carvedilol29$194
Rosuvastatin Calcium16$153
Metoprolol Succinate16$141
Tramadol Hcl59$135
Nifedipine ErNifedipine12$90
Furosemide45$76
Methocarbamol18$74
Pantoprazole Sodium16$67

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$6,36011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →